Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

During the Trading Day
89.58 +0.79 / +0.89%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
89.29 -0.29 / -0.32%
 
Volume: 29.0K

Today’s Trading

Previous close88.79
Today’s open87.61
Day’s range86.89 - 93.71
Volume448,442
Average volume (3 months)368,353
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+121.55%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+31.78%
P/E ratio7.4
Price/Sales17.67
Price/Book66.04

Competitors

 Today’s
change
Today’s
% change
USNAUSANA Health Science...-5.33-4.27%
RAREUltragenyx Pharmaceu...+0.92+1.81%
GLPGGalapagos NV-2.25-5.59%
ACADACADIA Pharmaceutica...+0.72+4.05%
Data as of 4:02pm ET, 02/09/2016

Financials

Next reporting dateFebruary 10, 2016
EPS forecast (this quarter)$0.65
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers